TFA Therapeutics, Inc.

RAJAF Biotech & pharma

Sells dietary supplements made from Cattle camphor mushroom.

Dec 2025Revenue $1.25M/yrExpenses $1.39M/yr
No trendCash runway ≈ 1 month from Dec 2025
Figures by year

When will TFA Therapeutics be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $1.25M and expenses $1.39M.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$1.25M$1.39M−$141K
Dec 2024$1.25M$1.44M−$184K
Dec 2023$883K$655K$228K
Dec 2022$53.3K$468K−$415K
Dec 2021$879K$999K−$119K